Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Fetscher

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Treatment of indolent lymphoma in Germany - results of a representative population-based surveyChristian Schmidt, Sebastian Fetscher, Christian Görg, et al.
British Journal of Haematology|March 22, 2003
Successful combination of anti-CD33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemiaMathias Hänel, Christian Thiede, Anett Helwig, et al.
Journal of Cancer Research and Clinical Oncology|October 18, 2018
Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphomaHanno M Witte, Armin Riecke, Thomas Mayer, et al.
Onkologie|October 8, 2010
Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in GermanyRalf-Dieter Hofheinz, Salah-Eddin Al-Batran, Karsten Ridwelski, et al.
Journal of Cancer Research and Clinical Oncology|August 20, 2021
Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategiesNiklas Gebauer, Britta Mengler, Svenja Kopelke, et al.
Cancers|April 15, 2020
The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell TransplantationHanno M Witte, Bastian Bonorden, Armin Riecke, et al.
Haematologica|November 11, 2003
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantationJohannes Schetelig, Sebastian Fetscher, Albrecht Reichle, et al.
Journal of Hematology & Oncology|August 16, 2022
Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German RegistryJudith Penkert, Farina J Strüwe, Christina M Dutzmann, et al.
Cancer Discovery|May 27, 2018
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Treatment of indolent lymphoma in Germany - results of a representative population-based surveyChristian Schmidt, Sebastian Fetscher, Christian Görg, et al.
British Journal of Haematology|March 22, 2003
Successful combination of anti-CD33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemiaMathias Hänel, Christian Thiede, Anett Helwig, et al.
Journal of Cancer Research and Clinical Oncology|October 18, 2018
Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphomaHanno M Witte, Armin Riecke, Thomas Mayer, et al.
Onkologie|October 8, 2010
Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in GermanyRalf-Dieter Hofheinz, Salah-Eddin Al-Batran, Karsten Ridwelski, et al.
Journal of Cancer Research and Clinical Oncology|August 20, 2021
Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategiesNiklas Gebauer, Britta Mengler, Svenja Kopelke, et al.
Cancers|April 15, 2020
The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell TransplantationHanno M Witte, Bastian Bonorden, Armin Riecke, et al.
Haematologica|November 11, 2003
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantationJohannes Schetelig, Sebastian Fetscher, Albrecht Reichle, et al.
Journal of Hematology & Oncology|August 16, 2022
Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German RegistryJudith Penkert, Farina J Strüwe, Christina M Dutzmann, et al.
Cancer Discovery|May 27, 2018
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.
Pageof 2